je.st
news
Tag: treatment
40 Years Serving the Water and Wastewater Treatment Industries
2014-09-19 06:00:00| Industrial Newsroom - All News for Today
CHLORINATORS INCORPORATED:WEFTEC EXHIBITOR BOOTH 8845 FOR IMMEDIATE RELEASE:SEPTEMBER, 2014…Chlorinators Incorporated is pleased to announce our participation at WEFTEC celebrating 40 years serving the water quality industry. With the design of the first direct-cylinder mounted all-vacuum gas chlorinator in 1960, a new company was formed in 1975 releasing another safer and more efficient product design. In 2015 we are commemorating 40 years of service to the water and wastewater ...
Tags: years
water
treatment
industries
OKI Delivers Additional Exhaust Gas Treatment Equipment for ON Semiconductor's European plants
2014-09-16 06:00:00| Industrial Newsroom - All News for Today
TOKYO - OKI Engineering, provider of reliability evaluations and environmental conservation technologies for the OKI Group, recently delivered an additional unit of KGT-3MM-AP exhaust gas treatment equipment for atmospheric pressure CVD*1 manufacturing equipment to semiconductor manufacturer ON Semiconductor's European plants. OKI Engineering's exhaust gas treatment equipment adopt a filter designed to minimize filter clogging, allowing extended maintenance-free use, ultimately ...This story is related to the following:Exhaust Filters |
Tags: additional
equipment
treatment
gas
Merck Announces Data from Pivotal Phase 3 Fracture Outcomes Study for Odanacatib, an Investigational Oral, Once-Weekly Treatment for Osteoporosis
2014-09-15 19:30:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. Merck now expects to submit the New Drug Application for odanacatib with the U.S. Food and Drug Administration (FDA) in 2015 WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced data from the pivotal Phase 3 fracture outcomes study for odanacatib in postmenopausal women with osteoporosis. Odanacatib is Mercks investigational once-weekly cathepsin K inhibitor. In the Long-Term Odanacatib Fracture Trial (LOFT), odanacatib met its primary endpoints and significantly reduced the risk of osteoporotic hip, spine and non-vertebral fractures compared with placebo. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Tracy Ogden, 215-370-5597orInvestors:Justin Holko, 609-915-8293 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: for
data
study
treatment
Varian Medical Systems Completes Commissioning of Five Proton Therapy Treatment Rooms Plus ...
2014-09-12 06:00:00| Industrial Newsroom - All News for Today
ProBeam version 2.5 successfully installed to enhance workflow at the San Diego site; technology is on display at the ASTRO meeting in San Francisco<br /> <br /> SAN FRANCISCO - ASTRO Booth #618 - Varian Medical Systems (NYSE: VAR) today announced that the company completed commissioning of five treatment rooms at the Scripps Proton Therapy Center earlier this year, and has upgraded the ProBeam® system software. The upgrade to ProBeam 2.5 will enhance workflow at the site, enable the use of ...This story is related to the following:Vision SystemsMedical & Health Care Software | Radiotherapy Systems
Tags: plus
systems
medical
treatment
Power, Water And Wastewater Are Three Big Water Treatment Chemicals Markets
2014-09-11 12:45:11| oilandgasonline Home Page
The power industry will buy 20 percent of the water treatment chemicals purchased by industries around the world in 2015. This is the conclusion of the McIlvaine Company in its Water and Wastewater Treatment Chemicals: World Market.
Tags: power
big
water
treatment
Sites : [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] next »